Synapse Open Synapse
Biology

Autoantibodies associate with clinical outcome in patients with melanoma treated with a dendritic cell-based vaccine

Nature Biological Sciences · · 1 min read

NCT01622933 was a clinical trial of an autologous dendritic cell-based vaccine in patients with melanoma. Here the authors show that the vaccine results in the induction of de novo autoantibodies associated with a favourable clinical outcome.

Latest from Nature Biological Sciences